Rheumatoid Arthritis

	11/05/2009	Comorbidity in Patients with Rheumatoid Arthritis: What are the Real Concerns?
	10/21/2009	Advances in Basic Science
	10/09/2009	Quantitatively-Driven Management of Rheumatoid Arthritis
	09/30/2009	Cancer, Liver, Infections, Cardiovascular Disease, and other Biologic Agents
	09/25/2009	Rheumatoid Arthritis: Clinical Aspects, Outcomes, and Measures
	09/21/2009	Applying Research to Your Practice: Focus on Nonbiologic DMARDs in 2009
	09/09/2009	Defining Clinical Practice in Early Rheumatoid Arthritis: An Expert Discussion
	09/09/2009	Standard Therapies and New Treatment Strategies: Identifying the Best Approaches
	09/09/2009	Applying Data to Practice: Case Vignettes
	08/18/2009	The Epidemiology of Increased Cardiovascular Death in Inflammatory Arthritis
	07/03/2009	Safety of Novel Immunomodulatory Therapies
	07/01/2009	Rheumatoid Arthritis: The Heart of the Matter Assessing Cardiovascular Risk in Patients with Rheumatoid Arthritis
	06/19/2009	New Recommendations for Disease-Modifying Antirheumatic Drugs and Emerging Options for the Treatment of Rheumatoid Arthritis
	06/02/2009	Failing a TNF Inhibitor: What About Switching?
	04/08/2009	Benefits of Early, Aggressive, and Appropriate Intervention in Rheumatoid Arthritis
	04/08/2009	The Rationale for Early Treatment in Rheumatoid Arthritis
	04/08/2009	Managing and Monitoring Response to RA Therapy
	04/08/2009	Applying Concepts to Practice in a Patient With Early Rheumatoid Arthritis
	04/06/2009	The Effect of Biologic Agents on Humoral Immunity: Significance of Immunoglobulins and Response to Vaccines
	03/31/2009	Relative Risks of Serious Bacterial and Opportunistic Infections Among Biologics: Results of Randomized Trials and Observational Studies
	03/19/2009	Current Perspectives and Latest Data in Undifferentiated Inflammatory & Rheumatoid Arthritis
	03/19/2009	Seizing the Opportunity for Early and Aggressive Intervention in Arthritis: Latest Assessment Tools and Optimal Positioning of Therapies
	03/19/2009	Assessing the Efficacy of Non-TNF Biologics in Rheumatoid Arthritis: What Does the Latest Evidence Show?
	03/19/2009	Examining the Safety of Non-TNF Biologics in Rheumatoid Arthritis: What Does the Latest Evidence Show?
	03/16/2009	Prevention of Infection in Rheumatoid Arthritis Patients Receiving Biologic Agents
	03/04/2009	Expert Opinions in Rheumatology Update on Safety and Efficacy of TNF Antagonists
	02/12/2009	Using Biologics to Improve Both Physical and Social Function in Rheumatic Diseases
	02/12/2009	Rheumatic Diseases: Using Anti-TNF-alpha Agents to Improve Everyday Patient Function
	02/12/2009	Treating to Target: Long-Term Safety and Efficacy in Rheumatoid Arthritis
	01/28/2009	Rheumatoid Arthritis and Imaging